Ronald Mathieu

Ronald Mathieu

Auto-generated profile, based on publicly available information

Ronald Mathieu

Flow Cytometry Core Facility, Boston Children's Hospital, Boston, MA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2016 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
RRR. Grant Rowe
R. Grant Rowe
LWLeo D. Wang
Leo D. Wang
SCSilvia Coma
Silvia Coma
AHAreum Han
Areum Han
RMRonald Mathieu
Ronald Mathieu
GDGeorge Q. Daley
George Q. Daley
For appropriate development, tissue and organ system morphogenesis and maturation must occur in synchrony with the overall developmental requirements of the host. Mistiming of such developmental events often results in disease. The hematopoietic system matures from the fetal state, characterized by robust erythrocytic output that supports prenatal growth in the hypoxic intrauterine environment, to the postnatal state wherein granulocytes predominate to provide innate immunity. Regulation of the developmental timing of these myeloerythroid states is not well understood. In this study, we find that expression of the heterochronic factor Lin28b decreases in common myeloid progenitors during hematopoietic maturation to adulthood in mice. This decrease in Lin28b coincides with accumulation of mature let-7 microRNAs, whose biogenesis is regulated by Lin28 proteins. We find that inhibition of let-7 in the adult hematopoietic system recapitulates fetal erythroid-dominant hematopoiesis. Conversely, deletion of Lin28b or ectopic activation of let-7 microRNAs in the fetal state induces a shift toward adult-like myeloid-dominant output. Furthermore, we identify Hmga2 as an effector of this genetic switch. These studies provide the first detailed analysis of the roles of endogenous Lin28b and let-7 in the timing of hematopoietic states during development.

6 February 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
RRR. Grant Rowe
R. Grant Rowe
EREdroaldo Lummertz da Rocha
Edroaldo Lummertz da Rocha
PSPatricia Sousa
Patricia Sousa
PMPavlos Missios
Pavlos Missios
MMMichael Morse
Michael Morse
GDGeorge Q. Daley
George Q. Daley
Leukemia phenotypes vary with age of onset. Delineating mechanisms of age specificity in leukemia could improve disease models and uncover new therapeutic approaches. Here, we used heterochronic transplantation of leukemia driven by MLL/KMT2A translocations to investigate the contribution of the age of the hematopoietic microenvironment to age-specific leukemia phenotypes. When driven by MLL-AF9, leukemia cells in the adult microenvironment sustained a myeloid phenotype, whereas the neonatal microenvironment supported genesis of mixed early B cell/myeloid leukemia. In MLL-ENL leukemia, the neonatal microenvironment potentiated B-lymphoid differentiation compared with the adult. Ccl5 elaborated from adult marrow stroma inhibited B-lymphoid differentiation of leukemia cells, illuminating a mechanism of age-specific lineage commitment. Our study illustrates the contribution of the developmental stage of the hematopoietic microenvironment in defining the age specificity of leukemia.